瑞舒伐他汀钙对短暂性脑缺血发作患者疗效及血脂水平的影响观察

Observation on the effect of rosuvastatin calcium on patients with transient ischemic attack with normal blood lipids and its effect on blood lipid levels

目的:探讨瑞舒伐他汀钙治疗短暂性脑缺血患者的临床价值。方法:2018年1-12月收治短暂性脑缺血发作患者80例,分为两组,各40例。对照组接受常规治疗,观察组接受常规+瑞舒伐他汀钙治疗。对比两组治疗效果。结果:观察组治疗后缺血性脑血管病发生率低于对照组,血脂指标水平改善情况优于对照组,差异有统计学意义(P<0.05)。结论:在常规治疗基础上联合使用瑞舒伐他汀钙治疗短暂性脑缺血,可获得理想的治疗效果,有效控制缺血性卒中发生风险。

Objective:To explore the clinical value of rosuvastatin calcium in the treatment of transient ischemic attack.Methods:80 patients with transient ischemic attack were selected from January to December 2018,they were divided into the two groups with 40 cases in each group.The control group received conventional treatment,the observation group received conventional and rosuvastatin calcium treatment.We compared the effects of the two groups.Results:The incidence of ischemic cerebrovascular disease in the observation group was lower than that in the control group,and the level of blood lipid in the observation group was better than that in the control group after treatment,the differences were statistically significant(P<0.05).Conclusion:On the basis of conventional treatment,the combination of rosuvastatin calcium in the treatment of transient cerebral ischemic diseases can obtain the ideal therapeutic effect,promote the patient's condition to improve as soon as possible,effectively control the risk of ischemic stroke.